Litigation Details for Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc. (D. Del. 2014)
✉ Email this page to a colleague
Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc. (D. Del. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-02-27 |
| Court | District Court, D. Delaware | Date Terminated | 2016-02-29 |
| Cause | 35:271 Patent Infringement | Assigned To | Sue Lewis Robinson |
| Jury Demand | None | Referred To | |
| Patents | 7,601,758; 7,619,004; 7,820,681; 7,906,519; 7,915,269; 7,935,731; 7,964,647; 7,964,648; 7,981,938; 8,093,296; 8,093,297; 8,093,298; 8,097,655; 8,415,395; 8,415,396; 8,440,721; 8,440,722 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc. (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-02-27 | 1 | of COLCRYS®. A. United Sates Patent Number 7,619,004 (“the ‘004 Patent”), entitled “METHODS FOR CONCOMITANT…722 Patents are collectively referred to herein as the “Patents.” l6. Takeda has submitted patent information…the inventor. B. United States Patent Number 7,6()1,758 (“the ‘758 Patent”), entitled “METHODS FOR CONCOMITANT…Page|D #: 4 C. United States Patent Number 7,820,681 (“the ‘681 Patent”), entitled “METHODS FOR CONCOMITANT…the inventor. D. United States Patent Number 7,915,269 (“the ‘269 Patent”), entitled “METHODS FOR CONCOMITANT | External link to document | |
| 2014-06-23 | 29 | amp; Gout Count V U.S. Patent 7,619,004 Treatment of Gout Count V1 U.S. Patent 7,601,75 8 Treatment of… was filed in 2008, resulting in U.S. Patent No. 7,619,004. Case 1:14-cv-00268-SLR Document 29 Filed …Watson wins this patent litigation with respect to the FMF patents 1f the Orange Book patents for Watson’s…PROCEEDING This is a patent infringement lawsuit involving several Takeda patents that purport to cover…Goggin Ex. 7.) These patent applications ultimately matured into the 17 patents that Takeda seeks to | External link to document | |
| 2014-02-27 | 3 | of the Patent: 7,619,004 expires 12/3/28* Thirty Month Stay Deadline: July 31, 2016 * 7,601,758 expires… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …Received Notice: 1/31/14. Date of Expiration of Patent: SEE FORM.Thirty Month Stay Deadline: 7/31/2016… Civil Aetion No. SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG APPLICATION… 29 February 2016 1:14-cv-00268-SLR Patent None District Court, D. Delaware | External link to document | |
| 2014-09-04 | 36 | . I. 19, ex. 1 at~ 17)3 Fourteen patents- U.S. Patent Nos. 7,619,004; 7,601 ,758; 7,820,681; 7,915,269…gout (the "gout patents"). (/d. at~ 15) Five patents- U.S. Patent Nos. 7,906,519; 7,935…,648 ("the '648 patent"), and 8,093,297 ("the 297 patent")- include claims directed…7,935, 731; 8,093,298; the '648 patent; and the 297 patent- include claims directed to the treatment…FMF (the "FMF patents"). (/d. at ~ 14) The '648 and '297 patents include claims directed | External link to document | |
| 2014-09-04 | 37 | G. United States Patent Number 7,601,758 (“the ‘758 Patent”), entitled “METHODS FOR CONCOMITANT… A. United Sates Patent Number 7,906,519 (“the ‘519 Patent”), entitled “METHODS FOR CONCOMITANT… B. United States Patent Number 7,935,731 (“the ‘731 Patent”), entitled “METHODS FOR CONCOMITANT… C. United States Patent Number 8,093,298 (“the ‘298 Patent”), entitled “METHODS FOR CONCOMITANT… D. United States Patent Number 7,964,648 (“the ‘648 Patent”), entitled “METHODS FOR CONCOMITANT | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
